Temporal Lobe Injury after Re-Irradiation of Locally Recurrent Nasopharyngeal Carcinoma Using Intensity Modulated Radiotherapy: Clinical Characteristics and Prognostic Factors.

Shuai Liu,Taixiang Lu,Chong Zhao,Jingxian Shen,Yunming Tian,Ying Guan,Lei Zeng,Weiwei Xiao,Shaomin Huang,Fei Han
DOI: https://doi.org/10.1007/s11060-014-1513-3
2014-01-01
Journal of Neuro-Oncology
Abstract:Temporal lobe injury (TLI) is a debilitating complication after radiotherapy for nasopharyngeal carcinoma (NPC), especially in patients who suffer treatment relapses and receive re-irradiation. We explored the clinical characteristics and prognostic factors of TLI in locally recurrent NPC (rNPC) patients after re-irradiation using intensity modulated radiotherapy (IMRT). A total of 454 temporal lobes (TLs) from 227 locally rNPC patients were reviewed. The clinical characteristics of TLI were analyzed. In the two radiotherapy courses, the equivalent dose in 2 Gy per fraction (EQD2) for the TLs was recalculated to facilitate comparison of the individual data. The median follow-up time was 31 (range, 3–127) months. After re-irradiation using IMRT, 31.3 % (71/227) of patients developed TLI. The median latency of TLI was 15 (range, 4–100) months. Univariate and multivariate analysis showed that the interval time (IT) between the two courses of radiotherapy and the summation of the maximum doses of the two radiotherapy courses (EQD2 − ∑max) were independent factors influencing TLI. The 5-year incidence of TLI for an IT ≤26 or >26 months was 35.9 and 53.7 % respectively (p = 0.024). The median maximum doses delivered to the injured TLs were significantly higher than was the case for the uninjured TLs after two courses of radiotherapy (135.3 and 129.8 Gy, respectively: p < 0.001). The incidence of TLI with an EQD2 − ∑max < 125 Gy was <5 %, and with an EQD2 − ∑max <145 Gy it was <50 %. A treatment mode limiting EQD2 − ∑max <125 Gy with a >2-year interval was found to be relatively safe.
What problem does this paper attempt to address?